Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Concurrent Lymphoid Malignancy

Allogeneic hematopoietic cell transplantation (HCT) can be curative for both myelodysplastic syndromes (MDS) and lymphoid malignancies. Little is known about the efficacy of allogeneic HCT in patients in whom both myeloid and lymphoid disorders are present at the time of HCT. We analyzed outcomes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmerman, Zachary, Scott, Bart L., Gopal, Ajay K., Sandmaier, Brenda M., Maloney, David G., Deeg, H. Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237793/
https://www.ncbi.nlm.nih.gov/pubmed/21909142
http://dx.doi.org/10.1038/bmt.2011.180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237793/
https://www.ncbi.nlm.nih.gov/pubmed/21909142
http://dx.doi.org/10.1038/bmt.2011.180

Ejemplares similares